Shopping Cart
Remove All
Your shopping cart is currently empty
DT-6, a potent TGF-β1 inhibitor, impedes M2 macrophage-induced epithelial-to-mesenchymal transition and the invasive migration of cancer cells, thereby showing potential for cancer research applications [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | 8-10 weeks | 8-10 weeks | |
| 50 mg | Inquiry | 8-10 weeks | 8-10 weeks |
| Description | DT-6, a potent TGF-β1 inhibitor, impedes M2 macrophage-induced epithelial-to-mesenchymal transition and the invasive migration of cancer cells, thereby showing potential for cancer research applications [1]. |
| In vitro | DT-6, at concentrations ranging from 0.1-50 μM for 0-18 hours, reduced the protein expression of TGF-β1 in various cell lines, including THP-1, BV2, A549, MCF-7, U87, and HepG2 [1]. Additionally, a 50 μM dose of DT-6 over a 24-hour period decreased the secretion of TGF-β1 in M2 macrophages cultured in conditioned medium (CM) [1]. Furthermore, at 20 μM and 50 μM for 24 and 48 hours, DT-6 inhibited the ability of M2 macrophages to induce epithelial-to-mesenchymal transition (EMT) and the invasive migration of cancer cells by reducing the secretion of TGF-β1 [1]. |
| Molecular Weight | 2008.23 |
| Formula | C89H130N20O29S2 |
| Cas No. | 2414315-95-8 |
| Smiles | O=C1C=2C(C(=O)N1C3C(=O)NC(=O)CC3)=CC=CC2OCC(NCCCCCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC=4C=5C(NC4)=CC=CC5)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC(N)=O)C(O)=O)=O)CCC(N)=O)=O)CCSC)=O)CCSC)=O)C)=O)=O)[C@H](CC)C)=O)[C@H](CC)C)=O)CO)=O)C)=O)CC(O)=O)=O)CC(C)C)=O)CO)=O)[C@@H](C)O)=O)=O |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.